dmp 323 has been researched along with nelfinavir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PS; Bacheler, LT; Chang, CH; Cordova, B; Erickson-Viitanen, S; Garber, S; Johnson, BL; Klabe, RM; Ko, SS; Lam, PY; Li, R; Reid, C; Rodgers, JD; Ru, Y; Seitz, SP; Trainor, GL; Wang, H; Wright, MR | 1 |
| Danielson, UH; Hallberg, A; Hämäläinen, M; Karlén, A; Markgren, PO; Samuelsson, B; Schaal, W | 1 |
2 other study(ies) available for dmp 323 and nelfinavir
| Article | Year |
|---|---|
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors.
Topics: Animals; Anti-HIV Agents; Crystallography, X-Ray; Dogs; Drug Design; HIV; HIV Protease Inhibitors; Molecular Structure; Mutation; Protein Binding; Urea; Virus Replication | 1998 |
Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.
Topics: Biosensing Techniques; HIV Protease; HIV Protease Inhibitors; Kinetics; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance; Urea | 2002 |